Breaking
Loading breaking news...
Loading...
Northeast Herald Logo

18 pharma companies lose licence for manufacturing spurious drugs

New Delhi: The government has cancelled the licences of 18 pharma companies for producing spurious and adulterated drugs, following joint inspections by central and state regulators at 76 drug manufacturers, a media report said.

IBNS
5 min read
18 pharma companies lose licence for manufacturing spurious drugs
Share this article:

The inspections were conducted across 20 states and Union territories in the past 15 days, the report said citing officials.

This is just the initial phase in the crackdown on companies involved in producing substandard medicines.

The authorities have cancelled the licences of 18 companies, while 26 companies have been issued show-cause notices, said the report.

During the drive, the regulators identified 203 firms. Most of the companies are from Himachal Pradesh (70), followed by Uttarakhand (45) and Madhya Pradesh (23), said the report.

Recently, some Indian pharma companies have come under the scanner of national and state drug regulators after drugs exported by them triggered negative reports.

Tags:
#agartala news#tripura news#northeast herald#news news

IBNS

Senior Staff Reporter at Northeast Herald, covering news from Tripura and Northeast India.

Related Articles

AI Robot replaces humans in dangerous canal cleaning in Thiruvananthapuram — Here’s how G-SPIDER works

AI Robot replaces humans in dangerous canal cleaning in Thiruvananthapuram — Here’s how G-SPIDER works

Under the Swachh Bharat Mission–Urban 2.0, the Thiruvananthapuram Municipal Corporation in south India has deployed an AI-powered G-SPIDER robotic system to enable safe, precise, and human-free canal cleaning in high-risk areas.

IBNSMar 06
One in five kids now overweight: Study highlights global obesity crisis

One in five kids now overweight: Study highlights global obesity crisis

The World Obesity Federation has warned on Wednesday that the world was set to miss the 2025 global target to halt the rise in childhood obesity. And despite the deadline now being extended to 2030, most countries remain off track.

IBNSMar 04
Breast cancer cases expected to reach over 3.5 million globally by 2050: Study

Breast cancer cases expected to reach over 3.5 million globally by 2050: Study

Despite recent advancements in breast cancer treatments, new breast cancer cases in women are predicted to rise by a third globally from 2.3 million in 2023 to more than 3.5 million in 2050. Similarly, yearly deaths from the disease are projected to surge 44%, from around 764,000 to 1.4 million, with disproportionate impact in countries with limited resources, according to a major new analysis from the Global Burden of Disease Study Breast Cancer Collaborators, published in The Lancet Onco...

IBNSMar 03
Modi launches nationwide HPV vaccine drive, calls it a game-changer for India’s daughters

Modi launches nationwide HPV vaccine drive, calls it a game-changer for India’s daughters

Prime Minister Narendra Modi launched the nationwide HPV vaccination campaign from Ajmer, Rajasthan, describing it as a pivotal step toward empowering India’s ‘Nari Shakti’ (women power) and ensuring the health of mothers and daughters.

IBNSFeb 28